Multiple Sclerosis depression reduced by 10,000 IU of vitamin D
Effect of vitamin D replacement on depression in multiple sclerosis patients.
Mult Scler Relat Disord. 2019 Jan 23;29:111-117. doi: 10.1016/j.msard.2019.01.029.
Kotb MA1, Kamal AM2, Aldossary NM3, Bedewi MA3.
📄 Download the PDF from Sci-Hub via VitaminDWiki

MS Depression - baseline

MS Depression after 8 months (note the change of scales)

BACKGROUND:
Multiple sclerosis (MS) is a chronic demyelinating disease of the central nervous system. Depression is common among MS patients. In patients without MS, lower vitamin D levels were associated with higher depression scores and severity. Supplementation of vitamin D was associated with significant improvement of depressive symptoms.
OBJECTIVE: to evaluate the relation between vitamin D levels and depression scores, and the effect of vitamin D replacement on the depressive symptoms in patients with MS.
METHODS:
The study included 35 patients with relapsing remitting multiple sclerosis. Neurological, psychiatric, and radiological evaluations were done. Participants received 10,000 IU of cholecalciferol daily for 12 months.
RESULTS:
Vitamin D level was low at baseline. Depressive symptoms were high at baseline and improved with vitamin D replacement although, Expanded Disability Status Scale (EDSS) score was not improving. Vitamin D levels correlated negatively with depressive symptoms at baseline and follow up periods.
CONCLUSION:
Lower vitamin D levels are associated with higher depressive scores, and vitamin D replacement could improve depressive symptoms in patients with relapsing remitting multiple sclerosis.